501 filings
EFFECT
CRMD
CorMedix Inc
23 May 24
Notice of effectiveness
12:15am
S-3
CRMD
CorMedix Inc
Shelf registration
9 May 24
5:06pm
10-Q
2024 Q1
CRMD
CorMedix Inc
Quarterly report
9 May 24
8:00am
8-K
CRMD
CorMedix Inc
9 May 24
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
7:40am
10-K
2023 FY
CRMD
CorMedix Inc
Annual report
12 Mar 24
8:15am
8-K
kgdou4swr488v514tj
12 Mar 24
CORMEDIX INC. REPORTS fourth QUARTER and full year 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
7:35am
8-K
a6rmetg9tvkj9zyw
30 Jan 24
CORMEDIX INC. announces commercial AND REiMBURSEMENT updates
5:26pm
8-K
1jkrcir48aw9l uleoy
15 Dec 23
Departure of Directors or Certain Officers
8:39am
8-K
4oezce bu1
16 Nov 23
CORMEDIX INC. ANNOUNCES FDA APProval of Defencath® To reduce
4:11pm
8-K
428xq 2sw6t972r5
14 Nov 23
Cormedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update
4:10pm
8-K
xqpz50m
30 Oct 23
Submission of Matters to a Vote of Security Holders
4:35pm
ARS
at6tbqn9ee
13 Sep 23
Annual report to shareholders
5:26pm
DEFA14A
lvixn50fw96
13 Sep 23
Additional proxy soliciting materials
5:25pm
8-K
nlby9atk5x
17 Aug 23
Departure of Directors or Certain Officers
8:30am
8-K
ir210ib7zed ikqguvzs
8 Aug 23
CorMedix Inc. Reports SECOND Quarter AND SIX MONTH 2023 Financial Results and Provides Business Update
7:45am
8-K
ikqgpsibkbmip61
30 Jun 23
Cormedix Inc. Announces Proposed Public Offering of Common Stock and Pre-funded Warrants
4:40pm
424B5
ujp01ojfm57z9wqrz1t0
30 Jun 23
Prospectus supplement for primary offering
4:38pm